Atlas Venture
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Early-stage biotechnology VC that explicitly builds breakthrough biotech companies; relevant for an AI-native longevity/drug-discovery platform at proof-of-concept stage.